Vivace Therapeutics, Inc. is a biotechnology research and small molecule discovery company located in San Mateo, California, dedicated to developing first-in-class cancer therapeutics.
Subscribe to see Vivace Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vivace Therapeutics, Inc. is a therapeutics company headquartered in San Mateo, United States. It has raised at least $78.1M across the 4 funding rounds on record. Its most recent funding round, Series D, raised $35M in March 2025. Xcout tracks 9 named people at Vivace Therapeutics, Inc., including Shuang Qiao (President & CEO).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for Vivace Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $78.1M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $35M | 3 named | |
| SEC Form D filing | $30M | — | |
| — | $8M | 3 named | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 3 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Vivace Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kronos Bio, Inc. is a clinical-stage biopharmaceutical company incorporated in 2017 and headquartered in San Mateo, California. The company is dedicated to discovering and developing small molecule therapeutics that target deregulated transcription.
Vivatides Therapeutics Inc. is a privately held biotechnology company founded in 2025 and headquartered in Woburn, Massachusetts. The company maintains a small team focused on therapeutics research and development.
Vivere Oncotherapies is a biotechnology research company co-founded by CEO Dr. Melissa Kotterman, focusing on unlocking the full potential of cancer therapies.
Novita Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in New York, New York, dedicated to developing first-in-class drugs to prevent and treat cancer.
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
January Therapeutics, Inc. is a privately held biotechnology company founded in 2017 and based in California, focused on developing next-generation targeted anti-cancer therapies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Vivace Therapeutics, Inc.? Suggest a correction · Work at Vivace Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.